← Leaderboards
Charandeep Singh
Massachusetts General Hospital
$890,147
Attributed
$890,147
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $462.1K · FY2021–25$500K$375K$250K$125K$0
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$890,147 · 2
By mechanism
R01$462,072 · 1
R21$428,075 · 1
Top collaborators
No co-investigators on record.
Most similar at Massachusetts General Hospital
Same institution · by research overlap
- Nima Saeidi$7,195,119
- Sam Sunghyun Yoon$2,703,621
- Kathryn J Moore$30,608,901
- Jeevendra Martyn$10,698,401
- Rajiv R Ratan$8,541,580
Others in their field
Other Emerging Leaders on “Metabolic”
- Xinhua Li · Nano Terra, Inc.$29,991,620
- Barbara Halina Braffett · George Washington University$22,016,904
- Ionut Bebu · George Washington University$18,816,779
- Jeremy James Martinson · University Of Pittsburgh At Pittsburgh$15,459,738
- Rainer Lohmann · University Of Rhode Island$14,400,221
- Leigh A Johnson · University Of North Texas Hlth Sci Ctr$14,236,023
Research focus
MetabolicOxidationFatty AcidsInfantMortalityMuller&AposExposure ToFatty Acid MetabolismGlucoseHyperoxiaAmmoniumEnzymesEndothelial CellsMouse StrainsBiomassCarbonAngiogenesisCell ProliferationBlindCell TypeBloodGlutamineCitric Acid CycleOxygen
Grant awards (3)
Metabolic basis of retinopathy of prematurity and potential treatment with anaplerotic substrates$462,072
R01 · FY2025 · EY · contact PI
Understanding metabolic mechanisms underlying retinopathy of prematurity$195,455
R21 · FY2022 · EY · contact PI
Understanding metabolic mechanisms underlying retinopathy of prematurity$232,620
R21 · FY2021 · EY · contact PI